Profile data is unavailable for this security.
About the company
Nova Eye Medical Limited is an Australia-based medical technology company that develops, manufactures, and sells a portfolio of proprietary ophthalmic treatment technologies and devices. The Company operates through three segments: AlphaRET, and Glaucoma surgical devices. The Company’s AlphaRET segment is responsible for the commercialization of the 2RT ophthalmic laser, which is an ophthalmic laser developed for the therapy of patients in the early to intermediate stages of age-related macular degeneration (AMD). 2RT is a patented nano-pulse laser device that rejuvenates retinal structures compromised by AMD. The Glaucoma Surgical Devices segment includes the designing, manufacturing, marketing, and sale of the iTrack, iTrack Advance and the Molteno3 glaucoma surgical device. The Molteno3 glaucoma drainage device platform is designed to enhance surgical utility and optimize clinical outcomes for long-term intraocular pressure (IOP) control in cases of severe glaucoma.
- Revenue in AUD (TTM)23.45m
- Net income in AUD-8.79m
- Incorporated1970
- Employees130.00
- LocationNova Eye Medical Ltd3-4 Second AvenueADELAIDE 5095AustraliaAUS
- Phone+61 88104-5200
- Fax+61 88104-5231
- Websitehttps://www.ellex.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Singular Health Group Ltd | 945.75k | -2.88m | 18.82m | -- | -- | 12.35 | -- | 19.89 | -0.018 | -0.0308 | 0.0063 | 0.0074 | 0.3536 | 8.73 | 22.14 | -- | -107.62 | -- | -331.71 | -- | 124.56 | -- | -304.36 | -- | 2.42 | -- | 0.1316 | -- | 112.26 | -- | 42.12 | -- | -- | -- |
| ImExHS Ltd | 24.68m | -3.42m | 19.05m | 400.00 | -- | 1.26 | -- | 0.7718 | -0.0794 | -0.0794 | 0.5713 | 0.3314 | 1.10 | 97.11 | 3.78 | 61,692.52 | -15.28 | -22.17 | -20.83 | -29.21 | 31.95 | 29.75 | -13.85 | -31.20 | 1.53 | -4.58 | 0.0593 | -- | 14.79 | 26.48 | -37.97 | -- | 5.61 | -- |
| Lumos Diagnostics Holdings Ltd | 17.25m | -13.32m | 23.86m | -- | -- | 1.49 | -- | 1.38 | -0.0276 | -0.0276 | 0.035 | 0.0215 | 0.426 | 4.37 | 7.02 | -- | -32.88 | -40.29 | -54.62 | -58.07 | 63.77 | 49.44 | -77.19 | -151.15 | 0.6949 | -6.01 | 0.5314 | -- | 5.66 | 19.53 | 4.22 | -- | -47.99 | -- |
| Cleanspace Holdings Ltd | 15.72m | -3.13m | 28.74m | -- | -- | 1.50 | -- | 1.83 | -0.0405 | -0.0405 | 0.2036 | 0.2469 | 0.5714 | 1.49 | 4.45 | -- | -11.37 | -3.31 | -13.04 | -4.14 | 72.25 | 74.42 | -19.89 | -4.38 | 3.92 | -- | 0.1528 | -- | 30.01 | 7.29 | 61.54 | -- | -20.61 | -- |
| Nova Eye Medical Ltd | 23.45m | -8.79m | 35.50m | 130.00 | -- | 1.66 | -- | 1.51 | -0.0436 | -0.0436 | 0.1149 | 0.0932 | 0.7785 | 0.7744 | 7.44 | -- | -29.18 | -15.92 | -36.41 | -18.97 | 86.64 | 83.45 | -37.49 | -57.51 | 1.84 | -19.35 | 0.1357 | -- | 36.90 | 7.54 | 42.52 | -- | -18.46 | -- |
| Universal Biosensors, Inc. | 7.08m | -12.39m | 35.77m | 97.00 | -- | 1.71 | -- | 5.05 | -0.0498 | -0.0498 | 0.0285 | 0.0701 | 0.2301 | 0.6592 | 4.25 | -- | -40.27 | -21.79 | -48.77 | -27.14 | 56.95 | 46.16 | -175.04 | -209.31 | 3.75 | -- | 0.0023 | -- | 46.58 | -37.48 | 74.90 | -- | 26.83 | -- |
| BCAL Diagnostics Ltd | 3.05m | -6.40m | 37.66m | -- | -- | 3.84 | -- | 12.36 | -0.0257 | -0.0257 | 0.0124 | 0.0273 | 0.2953 | -- | 1.03 | -- | -62.03 | -56.30 | -81.11 | -67.80 | -- | -- | -210.07 | -235.31 | -- | -128.30 | 0.1507 | -- | 9.18 | 64.04 | -26.44 | -- | 173.87 | -- |
| Curvebeam AI Ltd | 6.53m | -23.10m | 38.11m | 50.00 | -- | 1.01 | -- | 5.84 | -0.0774 | -0.0774 | 0.0222 | 0.1184 | 0.1047 | 0.3624 | 2.17 | -- | -37.05 | -- | -59.32 | -- | 46.08 | -- | -353.94 | -- | 1.54 | -14.28 | 0.2905 | -- | -18.97 | -- | 55.62 | -- | -- | -- |
| Cardiex Ltd | 11.18m | -6.77m | 39.71m | 26.00 | -- | 9.72 | -- | 3.55 | -0.0251 | -0.0251 | 0.0501 | 0.0139 | 0.8222 | 0.3786 | 8.61 | -- | -49.77 | -74.03 | -313.68 | -158.85 | 92.86 | 85.82 | -60.53 | -152.33 | 0.9687 | -2.22 | 0.4859 | -- | 129.87 | 22.44 | 64.18 | -- | -13.83 | -- |
| Micro-X Ltd | 15.22m | -9.77m | 40.13m | -- | -- | 2.81 | -- | 2.64 | -0.0187 | -0.0187 | 0.0289 | 0.0245 | 0.5323 | 0.9086 | 5.03 | -- | -34.15 | -39.41 | -48.53 | -50.99 | 62.05 | 64.09 | -64.15 | -108.20 | 1.68 | -38.35 | 0.2186 | -- | 1.45 | 23.43 | 9.20 | -- | -26.39 | -- |
| Holder | Shares | % Held |
|---|---|---|
| DFA Australia Ltd.as of 30 Sep 2024 | 0.00 | 0.00% |
